CatalystWireBeta

UK small-cap RNS · 23 Mar 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 07:00
    Final Results Results
    Profit from operations and EBITDA held flat despite higher employer NI and minimum wage costs, while cash rose to £3.9m, EPS grew and the dividend was raised 10%.
    Upgrade / downgrade cycle outlook mixedfirst in 7 months +0.0% on the day
    Moved: Ganymede rail and energy contracts: SRE 8-year award; E.ON extended 12 months → Order book described as strong and growing
  2. 07:00
    Transaction in Own Shares and Total Voting Rights Routine
  3. 07:00
    Final Results Results
    The R7.1bn loss and R8.8bn impairment were pre-flagged on 2 March and sit within that range, so 'ahead of expectations' overstates it. Production beat guidance and costs came in below it, but EBITDA fell 81% and the dividend was cut 69%.
    Disposal of a part (break-up) ahead of expectationsoutlook mixedfirst in 7 months −11.8% on the day
    Moved: PPE carrying value impairment assessment: Impairment of R8.8bn quantified; judgements being finalised → R8.8bn impairment recognised in FY2025 results (closed) · Goedehoop North disposal: Agreement signed; awaiting completion → Agreed; completion expected in 2026 · Kleinkopje mining right disposal: Agreement finalised; awaiting completion → Agreement concluded; completion expected 2026
  4. 07:00
    Transaction in Own Shares Routine
  5. 07:00
    Transaction in Own Shares Routine
  6. 07:00
    Transaction in Own Shares Routine
  7. 07:00
    Transaction in Own Shares Routine
  8. 07:00
    Transaction in Own Shares and Total Voting Rights Routine
  9. 07:00
    Update on Strategic Review
    Talks with both named bidders, Bridgepoint and Triton, have ended, leaving only unnamed parties in a sale process that has produced no offer. Takeover hopes fade after weak NHS trading.
    −22.5% on the day
    Moved: Strategic review and possible sale: Bridgepoint out; Rule 2.8 restrictions for 6 months → Both named bidders out; talks with others continue
  10. 07:00
    Final Results Results
    ("DF Capital" or the "Company" together with its subsidiaries the "Group")
    Upgrade / downgrade cycle ahead of expectations −1.8% on the day
  11. 07:00
    Transaction in Own Shares Routine
  12. 07:00
    Transaction in Own Shares Routine
  13. 07:00
    Transaction in Own Shares Routine
  14. 07:00
    Operations Update: Bonanza Vein
    Underground restart delivers early intersection of gold-bearing vein and high-precision development, enhancing near-term recovery potential
    first in 10 months +0.0% on the day
  15. 07:00
    Contract Announcement
    EM Solutions wins AU$21.7m (about £11.5m) to supply satellite terminals to the Portuguese Navy, adding to order book after intake slipped to 0.9x revenue at the interims. Delivery runs to 2030.
    £11.5m · 2% of mcapoutlook positive +0.0% on the day
    Moved: Second-half weighted delivery and margin recovery: Orders now fully cover consensus FY revenue → Further order wins add to order book
  16. 07:00
    IWG IWG £1,745m
    Transaction in Own Shares Routine
  17. 07:00
    Half-year Results Results
    Interim results for the six months ended 31 January 2026
    Upgrade / downgrade cycle ahead of expectations −7.2% on the day
  18. 07:00
    Currys CURY £1,473m
    Transaction in Own Shares Routine
  19. 07:00
    Transaction in Own Shares Routine
  20. 07:00
    Transaction in Own Shares Routine
  21. 07:00
    Transaction in Own Shares Routine
  22. 07:00
    Final Results Results
    ("Built Cybernetics", the "Company", or, together with its subsidiaries, the "Group")
    first in 9 months +0.0% on the day
  23. 07:00
    Transaction in Own Shares Routine
  24. 07:00
    Transaction in Own Shares Routine
  25. 07:00
    Transaction in Own Shares Routine
  26. 07:00
    Transaction in Own Shares Routine
  27. 07:00
    Final Results Results
    Revenue fell 14% to £1.38m and net loss widened to £2.61m, but the adjusted EBITDA loss narrowed to £1.68m and cash burn fell as costs were cut; elevate.io monetisation is still small.
    £1.4m · 9% of mcapoutlook positivefirst since Oct 2023 −7.3% on the day
    Moved: new: elevate.io product-market fit – 388 paying subscribers, ARR about $52k
  28. 07:00
    Issue of Equity to Directors Routine
  29. 07:00
    Transaction in Own Shares Routine
  30. 07:00
    Transaction in Own Shares Routine
  31. 07:00
    Transaction in Own Shares Routine
  32. 07:00
    Transaction in Own Shares Routine
  33. 07:00
    Transaction in Own Shares Routine
  34. 07:00
    Transaction in Own Shares Routine
  35. 07:00
    Ox-1 Programme Advances to Final Toxicology Study
    Lead Ox-1 Programme Advances to Final Toxicology Studies Before Human Phase 1 Clinical Study
    +0.0% on the day
  36. 07:00
    Transaction in Own Shares Routine
  37. 07:00
    Transaction in Own Shares Routine
  38. 07:00
    Transaction in Own Shares Routine
  39. 07:00
    Transaction in Own Shares Routine
  40. 07:00
    Final Results Results
    Revenue up 6.2% and underlying PBT up to £692k, ahead of market expectations. Net debt more than halved and the dividend is reinstated, though Toys, Sports & Leisure fell 17.5%.
    ahead of expectationsoutlook positive +6.0% on the day
    Moved: new: Chair succession – Chair to step down at forthcoming AGM
  41. 07:00
    Transaction in Own Shares Routine
  42. 07:00
    Notice of AGM & Annual Report Routine
  43. 07:00
    OSB Group OSB £1,615m
    OSB GROUP PLC - Transaction in Own Shares Routine

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note